Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
China CellSearch Study
- Status
- COMPLETED
- Phase
- N/A
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Triple Negative Breast Cancer Biomarker Study
- Status
- COMPLETED
- Phase
- N/A
Demonstrate Efficacy and Safety of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Safety, Efficacy and Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ixabepilone + Carboplatin Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Treatment With Ribavirin for Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
- Status
- COMPLETED
- Phase
- N/A
Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
- Status
- TERMINATED
- Phase
- PHASE2
A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline
- Status
- COMPLETED
- Phase
- PHASE2
Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant
- Status
- COMPLETED
- Phase
- PHASE2